Browsing: Pharmaceuticals
10 months ago
Piramal Enterprises Q2 Revenue Shows Moderate Growth
Amgen Beats Biocon to Market with Eylea Biosimilar, Impacting Biocon’s Outlook
Alembic Pharma Secures USFDA Final Approval for Diltiazem Hydrochloride Extended-Release Capsules (120 mg, 180 mg, 240 mg) with $28.2M Market Potential
Fermenta Biotech to Divest Mumbai Office Space for ₹40 Crore